What's new

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 7, Status: Authorised

Jun 19, 2025 - 15:05
 0
Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

US may be denying R&D grants for biotechs based on international investor links

Next Article

Sentry North 2025 Showcases Distributed Ops With F-35s

Related Posts

EMEA-003563-PIP01-23

EMEA-003563-PIP01-23

Jun 11, 2025  0

Superseded Community herbal monograph on Zingiber offic...

Jun 19, 2025  0

EMEA-003552-PIP01-23

EMEA-003552-PIP01-23

Jun 11, 2025  0